Caseware UK (AP4) 2024.0.164 2024.0.164 2024-06-302024-06-30false2023-07-01No description of principal activity5245truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 04470766 2023-07-01 2024-06-30 04470766 2022-07-01 2023-06-30 04470766 2024-06-30 04470766 2023-06-30 04470766 c:Director2 2023-07-01 2024-06-30 04470766 d:MotorVehicles 2023-07-01 2024-06-30 04470766 d:MotorVehicles 2024-06-30 04470766 d:MotorVehicles 2023-06-30 04470766 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 04470766 d:FurnitureFittings 2023-07-01 2024-06-30 04470766 d:FurnitureFittings 2024-06-30 04470766 d:FurnitureFittings 2023-06-30 04470766 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 04470766 d:ComputerEquipment 2023-07-01 2024-06-30 04470766 d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 04470766 d:Goodwill 2024-06-30 04470766 d:Goodwill 2023-06-30 04470766 d:FreeholdInvestmentProperty 2024-06-30 04470766 d:FreeholdInvestmentProperty 2023-06-30 04470766 d:CurrentFinancialInstruments 2024-06-30 04470766 d:CurrentFinancialInstruments 2023-06-30 04470766 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 04470766 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 04470766 d:ShareCapital 2024-06-30 04470766 d:ShareCapital 2023-06-30 04470766 d:RetainedEarningsAccumulatedLosses 2024-06-30 04470766 d:RetainedEarningsAccumulatedLosses 2023-06-30 04470766 c:FRS102 2023-07-01 2024-06-30 04470766 c:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 04470766 c:FullAccounts 2023-07-01 2024-06-30 04470766 c:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 04470766 d:AcceleratedTaxDepreciationDeferredTax 2024-06-30 04470766 d:AcceleratedTaxDepreciationDeferredTax 2023-06-30 04470766 e:PoundSterling 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure
Registered number: 04470766









DMN HEALTHCARE LIMITED

UNAUDITED

FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2024

 
DMN HEALTHCARE LIMITED
REGISTERED NUMBER: 04470766

BALANCE SHEET
AS AT 30 JUNE 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 5 
96,262
143,821

Investment property
 6 
315,657
315,657

  
411,919
459,478

Current assets
  

Debtors: amounts falling due within one year
 7 
1,416,216
1,036,911

Cash at bank and in hand
  
940,133
1,329,646

  
2,356,349
2,366,557

Creditors: amounts falling due within one year
 8 
(205,369)
(354,856)

Net current assets
  
 
 
2,150,980
 
 
2,011,701

Total assets less current liabilities
  
2,562,899
2,471,179

Provisions for liabilities
  

Deferred tax
 9 
(2,455)
(12,694)

  
 
 
(2,455)
 
 
(12,694)

Net assets
  
2,560,444
2,458,485


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
2,560,344
2,458,385

  
2,560,444
2,458,485


Page 1

 
DMN HEALTHCARE LIMITED
REGISTERED NUMBER: 04470766

BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 20 June 2025.




Mrs J F Fassihi
Director

The notes on pages 3 to 10 form part of these financial statements.

Page 2

 
DMN HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1.


General information

DMN Healthcare Limited is a private company limited by shares, incorporated in England and Wales, with a company registration number of 04470766. The address of the registered office is Anglia House, 6 Central Avenue, St Andrew's Business Park, Thorpe St Andrew, NR7 0HR.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Intangible assets

Goodwill
Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight line basis to the Profit and Loss Account over its useful economic life.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
DMN HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)


2.4
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Motor vehicles
-
25%
Reducing balance
Equipment
-
25%
Reducing balance
Computer equipment
-
25%
Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Profit and Loss Account.

 
2.5

Investment property

Investment property is carried at fair value determined annually by external valuers and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided. Changes in fair value are recognised in profit or loss.

 
2.6

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss).



Page 4

 
DMN HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)


2.6
Financial instruments (continued)

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

 
2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.8

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.9

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Page 5

 
DMN HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

3.


Employees

The average monthly number of employees, including directors, during the year was 52 (2023 - 45).


4.


Intangible assets




Goodwill

£



Cost


At 1 July 2023
200,000



At 30 June 2024

200,000



Amortisation


At 1 July 2023
200,000



At 30 June 2024

200,000



Net book value



At 30 June 2024
-



At 30 June 2023
-



Page 6

 
DMN HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

5.


Tangible fixed assets





Motor vehicles
Equipment
Total

£
£
£



Cost or valuation


At 1 July 2023
165,323
45,465
210,788


Additions
28,339
2,833
31,172


Disposals
(57,294)
-
(57,294)



At 30 June 2024

136,368
48,298
184,666



Depreciation


At 1 July 2023
39,850
27,117
66,967


Charge for the year on owned assets
20,307
7,097
27,404


Disposals
(5,967)
-
(5,967)



At 30 June 2024

54,190
34,214
88,404



Net book value



At 30 June 2024
82,178
14,084
96,262



At 30 June 2023
125,473
18,348
143,821

Page 7

 
DMN HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

6.


Investment property


Freehold investment property

£



Valuation


At 1 July 2023
315,657



At 30 June 2024
315,657

The 2024 valuations were made by the director, on an open market value for existing use basis.







7.


Debtors

2024
2023
£
£


Trade debtors
95,500
258,394

Amounts owed by associated company
428,712
443,585

Other debtors
744,788
242,128

Prepayments
7,920
11,716

Tax recoverable
139,296
81,088

1,416,216
1,036,911


Included within other debtors due within one year is an interest free loan due from Mr H Fassihi and Mrs J F Fassihi, the directors, amounting to £472,728 (2023 - £202,128).

The amount owed of £428,712 (2023 - £443,585) from a company with common shareholders has no formal terms of repayment and no formal agreed rate of interest.


8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
153,291
293,019

Other taxation and social security
5,648
10,262

Other creditors
39,157
43,642

Accruals
7,273
7,933

205,369
354,856


Page 8

 
DMN HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

9.


Deferred taxation




2024


£






At beginning of year
12,694


Charged to profit or loss
(10,239)



At end of year
2,455

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Accelerated capital allowances
2,455
12,694


10.


Prior year adjustment

The financial statements include a restatement from the prior year. The financial statements for the year ended 30 June 2023 included freehold property of £315,657, however this property is now considered investment property by the directors due to its usage.
As a result freehold property has been reclassified to investment property in the 30 June 2024 accounts, including the 30 June 2023 comparative.


11.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company  in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £1,376 (2023 £1,491).  The Company also made contributions to the directors pension scheme fund of £60,000 (2023 £223,000).
Contributions totalling £229 (2023 £115) were payable to the fund at the balance sheet date and are included in creditors.

Page 9

 
DMN HEALTHCARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

12.


Related party transactions

During the year the company had a directors loan account balance owing from Mr H and Mrs J F Fassihi. At 1 July 2023 the directors current account was a debit balance of £202,128, during the year monies were introduced of £50,810, dividends credited of £70,000, and withdrawals made of £391,410, leaving a debit balance of £472,728 owing to the company at 30 June 2024. The loan is interest free and repayable on demand.
During the year the company loaned monies to other companies in which directors have close relationships to the company directors.
The amount due from one company at 30 June 2024 was £37,960 (2023 £40,000), interest was charged, and the loan is repayable on demand.
The amount due from a second company at 30 June 2024 was £234,100 (2023 £Nil), interest was charged, and the loan is repayable on demand.


Page 10